Results
1 -
10 of
25
(Click
here to explore results)
- Drug Discovery from Natural Products, Chapter 15 Retapamulin: a First-in-Class Pleuromutilin Antibiotic. Rodger Novak
, 2012
, Pages 326-338
- Drug Discovery from Natural Products, Chapter 14 Natural Products: New Agents Against MDR Tuberculosis. Ujjini Manjunatha*, Fumiaki Yokokawa, Meera Gurumurthy, Thomas Dick
, 2012
, Pages 307-325
- Biocatalysis: An Industrial Perspective, CHAPTER 5 Bristol-Myers Squibb: Preparation of Chiral Intermediates for the Development of Drugs and APIs. Ramesh N. Patel
, 2018
, Pages 125-167
- Chemical and Biological Synthesis: Enabling Approaches for Understanding Biology, Chapter 11 Precursor-directed Biosynthesis and Semi-synthesis of Natural Products. Edward Kalkreuter, Samantha M. Carpenter, Gavin J. Williams
, 2018
, Pages 275-312
- Neglected Diseases and Drug Discovery, Chapter 13 Drug Discovery for Lower Respiratory Tract Infections. J Carl Craft
, 2012
, Pages 366-411
- Modern Biocatalysis: Advances Towards Synthetic Biological Systems, Chapter 9 Exploiting Biosynthetic Pathways in Fungi: Opportunities for Enhanced or Novel Production. Kate M. J. de Mattos-Shipley, Andy M. Bailey
, 2018
, Pages 234-260
- Pharmaceutical Salts and Co-crystals, Chapter 8 Application of Mechanochemistry in the Synthesis and Discovery of New Pharmaceutical Forms: Co-crystals, Salts and Coordination Compounds. Tomislav FrišČiĆ, William Jones
, 2012
, Pages 154-187
- Natural Product Chemistry for Drug Discovery, Chapter 1 Natural Products as Drugs and Leads to Drugs: The Historical Perspective. David J. Newman, Gordon M. Cragg
, 2009
, Pages 3-27
- New Applications of NMR in Drug Discovery and Development, Chapter 2 Solid‐State NMR in Drug Discovery and Development. Frederick G. Vogt
, 2013
, Pages 43-100
- Organometallic Chemistry: Volume 40, Overcoming synthetic challenges in target synthesis using SmI2: recent advances. Xavier Just-Baringo, Irem Yalavac, David Procter
, 2016
, Volume 40
, Pages 1-32